BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21620689)

  • 1. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis.
    Gandini S; Iodice S; Koomen E; Di Pietro A; Sera F; Caini S
    Eur J Cancer; 2011 Nov; 47(17):2607-17. PubMed ID: 21620689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues.
    Lens M; Bataille V
    Cancer Causes Control; 2008 Jun; 19(5):437-42. PubMed ID: 18197460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous melanoma in relation to exogenous hormones and reproductive factors.
    Holly EA; Weiss NS; Liff JM
    J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
    Osterlind A; Tucker MA; Stone BJ; Jensen OM
    Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.
    Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
    Melanoma Res; 2009 Oct; 19(5):327-32. PubMed ID: 19593232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.
    Naldi L; Altieri A; Imberti GL; Giordano L; Gallus S; La Vecchia C;
    Ann Epidemiol; 2005 Aug; 15(7):545-50. PubMed ID: 16029848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive use and malignant melanoma.
    Bain C; Hennekens CH; Speizer FE; Rosner B; Willett W; Belanger C
    J Natl Cancer Inst; 1982 Apr; 68(4):537-9. PubMed ID: 6951070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do hormones influence melanoma? Facts and controversies.
    Gupta A; Driscoll MS
    Clin Dermatol; 2010; 28(3):287-92. PubMed ID: 20541681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer.
    Martínez ME; Grodstein F; Giovannucci E; Colditz GA; Speizer FE; Hennekens C; Rosner B; Willett WC; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):1-5. PubMed ID: 8993789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer?
    Birch-Johansen F; Jensen A; Olesen AB; Christensen J; Tjønneland A; Kjær SK
    Cancer Causes Control; 2012 Feb; 23(2):379-88. PubMed ID: 22215431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study.
    Kvaskoff M; Bijon A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    Am J Epidemiol; 2011 May; 173(10):1192-202. PubMed ID: 21415032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
    Gandini S; Sera F; Cattaruzza MS; Pasquini P; Abeni D; Boyle P; Melchi CF
    Eur J Cancer; 2005 Jan; 41(1):28-44. PubMed ID: 15617989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal and reproductive factors and the risk of bladder cancer in women.
    McGrath M; Michaud DS; De Vivo I
    Am J Epidemiol; 2006 Feb; 163(3):236-44. PubMed ID: 16319290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive history, use of exogenous hormones, and risk of colorectal adenomas.
    Peipins LA; Newman B; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):671-5. PubMed ID: 9298573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.